AstraZeneca scores speedy FDA review for Farxiga based on 'innovative' heart attack trial design

17th July 2020 Uncategorised 0

AstraZeneca scores speedy FDA review for Farxiga based on ‘innovative’ heart attack trial design
kblankenship
Fri, 07/17/2020 – 08:55




More: AstraZeneca scores speedy FDA review for Farxiga based on 'innovative' heart attack trial design
Source: fierce